tbuckley/cabot-search huggingface dataset:
WED-279 Landscape of the steatotic liver disease and its risk factors in the point-of-care liver screening program SIRIUS
Authors: Tomas Koller, Svetlana Adamcova Selcanova, Natalia Kubanek, Daniel Jan Havaj, Karolina Sulejova, Daniela Žilinčanova, Sylvia Dražilová, Martin Janičko, Marek Rac, Maria Szantova, Lubomir Skladany
Journal: Journal of Hepatology (2024)
WED-212 Pemvidutide treatment is associated with improvement in non-invasive tests indicating greater likelihood of histologic response in subjects with metabolic dysfunction-associated steatotic liver disease: a 24-week, randomized, double-blind, placebo-controlled trial
Authors: Naim Alkhouri, Shaheen Tomah, John Suschak, Jonathan Kasper, M. Scot Roberts, M. Scott Harris, Sarah Browne, Rohit Loomba
Journal: Journal of Hepatology (2024)
WED-199 Optimizing MASLD trial recruitment: LiverPRO vs. FIB-4 in reducing false positives and unnecessary biopsies
Authors: Katrine Lindvig, Naim Alkhouri, Rida Nadeem, Aarya Patel, Manal Chughtai, Sahasraara Hemant, Yasmeen Fallouh, Himanshi Kapoor, Camilla Dalby Hansen, Katrine Thorhauge, Johanne Kragh Hansen, Stine Johansen, Helle Schnefeld, Peter Andersen, Ida Falk Villesen, Katrine Tholstrup Bech, Nikolaj Torp, Sönke Detlefsen, Mads Israelsen, Maja Thiele, Aleksander Krag
Journal: Journal of Hepatology (2024)
WED-198 Novel deep learning models utilising domain adaptation outperform conventional statistical models for predicting the risk of liver-related complications in patients with metabolic dysfunction-associated steatotic liver disease
Authors: Terry Cheuk-Fung Yip, Jingwen Xu, Mandy Sze-Man Lai, Sherlot Juan Song, Yee-Kit Tse, Henry L.Y. Chan, Grace Lai-Hung Wong, Pong Chi Yuen, Vincent Wai-Sun Wong
Journal: Journal of Hepatology (2024)
WED-248 A four-country modelling study on doubling MASH diagnostic rates by 2027
Authors: Jeffrey V Lazarus, Henry E Mark, William Alazawi, Alina M Allen, Paul N Brennan, Chris D Byrne, Laurent Castera, Cyrielle Caussy, Kenneth Cusi, Martin M Grajower, Morten Faarbæk Mikkelstrup, Michael Roden, Frank Tacke, Mazen Noureddin
Journal: Journal of Hepatology (2024)
WED-317 Guided Vibration-Controlled Transient Elastography, a new vibration-guided FibroScan examination
Authors: Jean-Pierre Bronowicki, Christiane Stern, Stéphane Audière, Julie Foucquier, Cécile Bastard, Anne Llorca, Céline Fournier-Poizat, Véronique Miette, Laurent Sandrin, Cyrielle Caussy
Journal: Journal of Hepatology (2024)
WED-271 Circulating vesicle microRNAs for metabolic dysfunction-associated steatotic liver disease (MASLD) staging and progression towards liver cancer
Authors: Laura Izquierdo-Sánchez, Ainhoa Lapitz, André Simão, Santiago Iturbe-Rey, Marco Arrese, Claudia P. Oliveira, Ignacio Aguirre Allende, Ainhoa Echeveste, Raul Jimenez-Aguero, Emma Eizaguirre, Jorge Arnold, Carmen M. Del Prado Alba, María Luz Martínez-Chantar, Kristina Schoonjans, Patricia Aspichueta, María Jesùs Perugorria, Luis Bujanda, Pedro M. Rodrigues, Jesus Maria Banales
Journal: Journal of Hepatology (2024)
THU-199 Role and therapeutic potential of miR-22 in MAFLD and obesity: from mouse model to human relevance
Authors: Riccardo Panella, Simone Tomasini, Anna Altieri, Francesco Margiotta, Philip Vonschallen, Ulrik Scheele, Lei Cai, Ryan Temel, Sakari Kauppinen
Journal: Journal of Hepatology (2024)
THU-198 In vitro and in vivo pharmacological characterization of human PNPLA3-targeting short interfering RNA molecules for the treatment of metabolic dysfunction-associated steatohepatitis
Authors: Jieun Song, Jerome Deval, Lillian Adame, Ruchika Jaisinghani, Emily Tso, Daniel Lin, Aneerban Bhattacharya, Antitsa Stoycheva, Jacquelyn Sousa, Craig Parish, Saul Martinez Montero, Vivek Rajwanshi, Shane Daguison, Vikrant Gohil, Qingling Zhang, Toni Williamson, Sushmita Chanda, Saswata Talukdar, David Smith, Leonid Beigelman, Julian Symons, Yingjiang Zhou, Xuan Luong
Journal: Journal of Hepatology (2024)
FRI-028 Spleen stiffness measurement improves non-invasive prediction of clinically significant portal hypertension in patients with compensated advanced chronic liver disease of mixed etiology
Authors: Giulia Francesca Manfredi, Angelo Strada, Mattia Lotto, Valentina Romano, Vincenzo Bonafede, Michela Burlone, Rosalba Minisini, Mario Pirisi, Cristina Rigamonti
Journal: Journal of Hepatology (2024)
SAT-245 Semaglutide for type 2 diabetes control in metabolic dysfunction-associated steatotic liver disease (MASLD): a two-way effect?
Authors: Giovanni Petralli, Antonio Salvati, Simone Cappelli, Gabriele Ricco, Lidia Surace, Ranka Vukotic, Piero Colombatto, Francesco Raggi, Anna Solini, Maurizia Brunetto
Journal: Journal of Hepatology (2024)
WED-267 The FAP Index: A statistical model aiding the detection of advanced liver fibrosis in people with diabetes, obesity or metabolic dysfunction-associated steatosis using a marker of activated stellate cells and myofibroblasts
Authors: Ziqi Vincent Wang, Badwi Boumelhem, William Bachovchin, Geraldine Ooi, Jacob George, Mohammed Eslam, Leon Adams, Hui Zhang, Geoff McCaughan, Avik Majumdar, Mark Gorrell
Journal: Journal of Hepatology (2024)
FRI-317 Clinical outcomes of metabolic liver disease versus non-alcoholic fatty liver disease: a meta-analysis of observational studies
Authors: Grazia Pennisi, Giuseppe Infantino, Ciro Celsa, Gabriele Di Maria, Marco Enea, Marco Vaccaro, Roberto Cannella, Carlo Ciccioli, Claudia La Mantia, Alessandro Mantovani, Francesco Mercurio, Herbert Tilg, Giovanni Targher, Vito Di Marco, Calogero Camma, Salvatore Petta
Journal: Journal of Hepatology (2024)
FRI-022 N-terminal type III collagen propeptide, golgi protein 73 and their combination accurately assess siginificant and advanced fibrosis in chronic hepatitis B patients
Authors: Qianqian Chen, Yee Hui Yeo, Xinyu Hu, Li Zhu, Fajuan Rui, Shengxia Yin, Chuanwu Zhu, CHao Wu, Mindie Nguyen, Jie Li
Journal: Journal of Hepatology (2024)
THU-242 Comparison ofmachine learning model (MASML), VCTE, and FIB-4 scores for predicting the presence of MASLD in a large cohort of patients in the U.S. using the NHANES database
Authors: Mazen Noureddin, Joseph Rubinsztain, Karen Taub, Devon Y. Chang, Stephen A. Harrison, Naim Alkhouri
Journal: Journal of Hepatology (2024)
TOP-229-YI The E2F2 target glycerophosphodiester phosphodiesterase domain containing 3 is involved in MASLD progression to HCC and related dyslipidemias
Authors: Maider Apodaka-Biguri, Nerea Muñoz-Llanes, Francisco Gonzalez-Romero, Igor Aurrekoetxea, Beatriz Gómez Santos, Igotz Delgado, Xabier Buque, Ane Nieva-Zuluaga, Mikel Ruiz de Gauna, Idoia Fernández-Puertas, Paul Gomez-Jauregui, Natalia Sainz-Ramírez, Kendall Alfaro-Jiménez, Estibaliz Castillero, Daniela Mestre Congregado, Ashwin Woodhoo, Marta Varela-Rey, Amaia Lujambio, Ana Zubiaga, Patricia Aspichueta
Journal: Journal of Hepatology (2024)
WED-293 Effectiveness of on different models of care based on Fibrosis-4 and/or liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease
Authors: Gian Paolo Caviglia, Arianna Ferro, Angelo Armandi, Roberta D'Ambrosio, Pietro Lampertico, Giulia Periti, Luca Valenti, Carlo Ciccioli, Grazia Pennisi, Salvatore Petta, Lucia Brodosi, Maria Letizia Petroni, Francesca Marchignoli, Loris Pironi, Alessandra Sagripanti, Maria Eva Argenziano, Gianluca Svegliati-Baroni, Gabriella Gruden, Elisabetta Bugianesi
Journal: Journal of Hepatology (2024)
THU-196 Targeting lysyl-tRNA synthetase alleviates metabolic dysfunction-associated steatohepatitis through inhibition of monocytederived macrophages in preclinical models
Authors: Junghyun Kim, Hyeree Kim, Kang Soo Lee, Hyuk-Sang Kwon, Nam Hoon Kim, Sunghoon Kim, Yeup Yoon, Wonseok Kang
Journal: Journal of Hepatology (2024)
FRI-273-YI Prevalence, characteristics and hepatic fibrosis burden of the different subtypes of steatotic liver disease among a cohort of Egyptian people living with HIV
Authors: Rahma Mohamed, Heba Omar, Naeema El Garhy, Ahmed Cordie, Hend Tamim, Zainab Masoud, Lamiaa Al Sehemy, Ammar Hatem, Reham Awad Awad, Mariam Ismail Abdelraouf, Aya M. Al-sharif, Mirella Sherif, Andrew Saweres, Remon Atef, Mohamed Nagy, Rania Hamza, Mona Salah Eldin Hamdy, Engy El Khateeb, Gamal Esmat
Journal: Journal of Hepatology (2024)
WED-269 Simultaneous assessment of skeletal muscle mass and handgrip strength to identify patients with NAFLD at high risk of advanced liver fibrosis
Authors: David Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos T. Pyrsopoulos, HyeWon Lee, Seung Up Kim
Journal: Journal of Hepatology (2024)
WED-286 Identification of serum metabolome signatures associated with hepatocellular carcinoma in metabolic dysfunction-associated steatohepatitis
Authors: Atsumasa Komori, Kosuke Matsumoto, Yuki Kugiyama, Tomoyuki Suehiro, Yasuhide Motoyoshi, Akira Saeki, Shinya Nagaoka, Kazumi Yamasaki, Hiroshi Yatsuhashi
Journal: Journal of Hepatology (2024)
WED-314-YI Head-to-head comparison of two different ultrasound systems to measure the liver attenuation parameter
Authors: Laura De Rosa, Simone Cappelli, Giovanni Petralli, Antonio Salvati, Gabriele Ricco, Filippo Oliveri, Barbara Coco, Piero Colombatto, Ferruccio Bonino, Maurizia Brunetto, Francesco Faita
Journal: Journal of Hepatology (2024)
SAT-248 Liver stiffness improvement with pioglitazone in brazilian patients with metabolic dysfunction-associated steatohepatitis: a multicentric pilot study
Authors: Mário Pessoa, Isabel Veloso Alves Pereira, Patricia Momoyo Zitelli, Mísia Joyner de Sousa Dias Monteiro, Cláudia Alves Couto, Juliana Souza de Oliveira, Renato Altikes, Ana Luiza Gomes Reis, Lais Arrivabene Barbieri, Nathalie Leite, Cristiane Villela-Nogueira, Claudia P. Oliveira
Journal: Journal of Hepatology (2024)
TOP-445 Associations of food insecurity and healthcare access with the prevalence and mortality of metabolic dysfunction-associated steatotic liver disease (MASLD): a global study of the United Nation and the global burden of disease data
Authors: Zobair Younossi, Shira Zelber-Sagi, Carina Kugelmas, Jeffrey V. Lazarus, Annette Paik, Leyla Deavila, Lynn Gerber, James M. Paik
Journal: Journal of Hepatology (2024)
FRI-251-YI Hepatic steatosis contributes to cognitive impairment in patients with metabolic dysfunction-associated steatotic liver disease and/or type 2 diabetes-mellitus
Authors: Nuria Pérez Diaz del Campo, Arianna Ferro, Gabriele Castelnuovo, Gian Paolo Caviglia, Chiara Rosso, Marta Guariglia, Eleonora Dileo, Angelo Armandi, Francesca Saba, Giorgio Maria Saracco, Federica Barutta, Guglielmo Beccuti, Gabriella Gruden, Elisabetta Bugianesi
Journal: Journal of Hepatology (2024)
FRI-226 The impact of light to moderate alcohol consumption on liver and cardiovascular damage in metabolic-dysfunction associated steatotic liver disease
Authors: Rosa Lombardi, Felice Cinque, Andrea Dalbeni, Annalisa Cespiati, Floriana Santomenna, Jaqueline Currà, Daniel Smith, Erika Fatta, Cristina Bertelli, Giuseppina Pisano, Edoardo Pulixi, Anna Mantovani, Mirko Zoncapè, David Sacerdoti, Anna Ludovica Fracanzani
Journal: Journal of Hepatology (2024)
FRI-486 Impact of proliferative and metabolic reprogramming by the lysine-specific demethylase 1 in hepatocellular carcinoma
Authors: Jie Wang, Lingyu Wang, Hardik Makwana, Marcel Schmiel, Yefeng Shen, Anton Ströbel, Hannah Eischeid-Scholz, Yue Zhao, Evangelos Kondylis, Mafalda Escobar, Michal Schweiger, Reinhard Büttner, Margarete Odenthal
Journal: Journal of Hepatology (2024)
TOP-307 The interplay between alcohol consumption and cardiometabolic risk factors in patients with MASLD and MetALD
Authors: Yee Hui Yeo, Fajuan Rui, Yixuan Zhu, Xiaoming Xu, Xiaoyan Ma, Wenjing Ni, Xinyu Hu, Chao Wu, Junping Shi, Jie Li, Philip N. Newsome
Journal: Journal of Hepatology (2024)
FRI-195 Genetically determined circulating protein biomarkers and risk of advanced fibrosis
Authors: Jun Wang, Gabriel Cuellar-Partida, Robert W. Read, Karen A. Schlauch, Gai Elhanan, W. James Metcalf, Lisa Boyette, Timothy R. Watkins, Joseph J. Grzymski, Scott D. Patterson, Shahed Iqbal, Andrew N. Billin
Journal: Journal of Hepatology (2024)
FRI-514 Fatty acids accumulate in intrahepatic cholangiocarcinomaderived tissue and sera
Authors: Stefania Mantovani, Michele Dei Cas, Barbara Oliviero, Linda Montavoci, Monica Falleni, Delfina Tosi, Matteo Donadon, Marcello Maestri, Matteo Barabino, Gaetano Piccolo, Mario Umberto Mondelli, Anna Caretti
Journal: Journal of Hepatology (2024)
FRI-200 Magnitude of steatotic liver disease before and after liver transplantation and the impact of immunosuppressive medication: a multidimensional study
Authors: Ibrahim Ayada, Jiajing Li, Jiahua Zhou, Laurens van Kleef, Willem Pieter Brouwer, Pengfei Li, Yasir J. Abozaid, Maikel P. Peppelenbosch, Harry L.A. Janssen, Mohsen Ghanbari, Luc van der Laan, Robert J. de Knegt, Caroline den Hoed, Qiuwei Pan
Journal: Journal of Hepatology (2024)
THU-475 Tumor burden incorporating AFP improves survival prediction for patients with HCC undergoing TACE: an international multicentre observational study
Authors: Dongdong Xia, Wei Bai, Qiuhe Wang, Jin Wook Chung, Xavier Adhoute, Roman Kloeckner, Hui Zhang, Yong Zeng, Pimsiri Sripongpun, Chunhui Nie, Seung Up Kim, Ming Huang, Wenhao Hu, Xiangchun Ding, Guowen Yin, Hailiang Li, Hui Zhao, Jing Li, Jiaping Li, Xiaoli Zhu, Jianbing Wu, Chunqing Zhang, Weidong Gong, Zixiang Li, Zhengyu Lin, Tao Xu, Tao Yin, Jinlong Song, Haibin Shi, Guoliang Shao, Weixin Ren, Yongjin Zhang, Shufa Yang, Yanbo Zheng, Jian Xu, Wenhui Wang, Xu Zhu, Dominik Bettinger, Arndt Vogel, Guohong Han
Journal: Journal of Hepatology (2024)
FRI-245 Longitudinal follow-up of Fib-4 in patients at risk of steatotic liver disease (SLD) receiving low-dose Methotrexate treatment (LDMTX): results from the CIRT randomized placebo-controlled Trial in 4769 patients
Authors: Vincent Di Martino, Jing Cui, Delphine Weil-Verhoeven, Daniel Solomon
Journal: Journal of Hepatology (2024)
THU-498 Safety and Efficacy of Atezolizumab-Bevacizumab in Non-Viral and Viral Etiologies of Hepatocellular Carcinoma: A Multicenter Retrospective Comparative Study
Authors: Anand Kulkarni, Karan Kumar, Mithun Sharma, Sameer Shaik, Sowmya Iyengar, Shantan Venishetty, Manasa Alla, Vivek Saraswat, Nagaraja Padaki, Nageshwar Reddy
Journal: Journal of Hepatology (2024)
SAT-498 Patterns and predictors of acute care utilization after liverdirected therapy for hepatocellular carcinoma
Authors: Andrew Moon, Chidi Iloabachie, Sydney Power, Gabriel Lupu, Joyce Badal, Yue Jiang, David Seligson, Hanna Sanoff, David Mauro, David Gerber, Ted Yanagihara, A. Sidney Barritt Iv
Journal: Journal of Hepatology (2024)
FRI-500-YI ERAL1 down-regulates NADH: ubiquinone oxidoreductase core subunit V1 through N6-methyladenosine reader Insulin like growth factor 2 mRNA binding protein 2 to inhibit mitochondrial adenosine triphosphate synthesis and metastasis in hepatoma cells
Authors: Li Zhou, Siqi Liao, Siyuan Chen, Song He, Zhihang Zhou
Journal: Journal of Hepatology (2024)
FRI-211 The presence of autoimmune characteristics in metabolic associated steatosis liver disease patients increases the risk of liver disease progression. Study from the multicentric spanish register (HEPAMET)
Authors: Anna Soria, Alba Díaz, Paula Iruzubieta, MTeresa Salcedo, Rosa María Martín Mateos, Marlene Padilla, Maria Teresa Arias Loste, Juan Manuel Pericàs, Alba Jiménez-Massip, Ana Ferrer, Carolina Jiménez González, Cristian Perna, Sergio Muñoz Martínez, Zyanya Calixto, Clara Sabiote, Ignasi Olivas, Helena Hernández Evole, Javier Crespo, Agustín Albillos, Pere Ginès, María Carlota Londoño, Isabel Graupera
Journal: Journal of Hepatology (2024)
FRI-474-YI Restoring retinoic acid receptor-related orphan receptor alpha reduces intrahepatic cholangiocarcinoma proliferation and modulates cancer-associated fibroblasts
Authors: Laura Sererols Viñas, Paula Cantallops Vilà, Raquel A. Martínez-García de la Torre, Gemma Garcia Vicién, Silvia Ariño, Carmen Cárcamo Giráldez, Joana Ferrer, Alejandro Forner, Loreto Boix, María Reig, Pau Sancho-Bru, Silvia Affo
Journal: Journal of Hepatology (2024)
TOP-506 Atezolizumab/bevacizumab as downstaging in hepatocellular carcinoma: an intention-to-transplant analysis
Authors: Marianna Maspero, Sherrie Bhoori, Veronica Fedele, Nicolò Simonotti, Valentina Bellia, Marco Bongini, Carlo Sposito, Vincenzo Mazzaferro
Journal: Journal of Hepatology (2024)
FRI-493 CLEC14A regulates neutrophil recruitment across liverendothelial cells and correlates with a neutrophil signature in hepatocellular carcinoma
Authors: Joanne O'Rourke, Daniel Patten, Dean Kavanagh, Catherine E. Willoughby, Tahir Shah, Yuk Ting Ma, Owen Cain, Derek A. Mann, Roy Bicknell, Shishir Shetty
Journal: Journal of Hepatology (2024)
FRI-243 Echocardiography-based markers of subclinical cardiac dysfunction in patients with MASLD and preserved ejection fraction: prospective data from the Turin cohort
Authors: Kamela Gjini, Angelo Armandi, Alessandro Andreis, Matteo Bellettini, Irene Poggiolini, Gabriele Castelnuovo, Gian Paolo Caviglia, Chiara Rosso, Nuria Pérez Diaz del Campo, Marta Guariglia, Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Davide Castagno, Alberto Milan, Fabrizio Amato, Martina Marano, Gaetano De Ferrari, Elisabetta Bugianesi
Journal: Journal of Hepatology (2024)
TOP-301 Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in steatotic liver disease
Authors: Serena Pelusi, Alfredo Marchetti, Francesco Malvestiti, Antony Ricchiuti, Luisa Ronzoni, Marta Lionetti, Vittoria Moretti, Elisabetta Bugianesi, Luca Miele, Umberto Vespasiani Gentilucci, Paola Dongiovanni, Alessandro Federico, Giorgio Soardo, Roberta D'Ambrosio, Helen Louise Reeves, Vincenzo La Mura, Daniele Prati, Niccolò Bolli, Luca Valenti
Journal: Journal of Hepatology (2024)
FRI-454 Prediction of TERT promoter mutations using MALDI imaging and artificial intelligence in small hepatocellular nodules in cirrhosis
Authors: Helene Cazier, Remy Dubois, Aurélie Beaufrère, Samira Laouirem, Sarah Paisley, Benoit Schmauch, Martin Tabath, Miguel Albuquerque, Valérie Paradis
Journal: Journal of Hepatology (2024)
THU-471-YI From randomised clinical trials to clinical practice: a systematic reviewand meta-analysis of real-word data on atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
Authors: Giulia Francesca Manfredi, Claudia Fulgenzi, Ciro Celsa, Bernardo Stefanini, Antonio D'Alessio, Matthias Pinter, Bernhard Scheiner, Nichola Awosika, Yi-Hsiang Huang, Chun-yen Lin, Andrea Dalbeni, Arndt Vogel, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Hong Jae Chon, Giuseppe Cabibbo, Fabio Piscaglia, Calogero Camma, Anjana Pillai, Mario Pirisi, Amit Singal, David J. Pinato
Journal: Journal of Hepatology (2024)
THU-516 Beneficial effect of combined radiation therapy in atezolizumab plus bevacizumab treatment of hepatocellular carcinoma patients with main portal vein tumor thrombosis
Authors: Sangyoun Hwang, Hyun Young Woo, Jeong Heo, Hyung Jun Kim, Young Joo Park, Kiyoun Yi, Yu Rim Lee, Soo Young Park, Woo Jin Chung, Byoung Kuk Jang, Won Young Tak
Journal: Journal of Hepatology (2024)
THU-485-YI Hepatic and peripheral blood neutrophil: lymphocyte ratios offer paradoxical associations with clinical outcome in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors plus transarterial chemoembolization
Authors: Paul Armstrong, Aoife Moriarty, Erinn McGrath, Jennifer Russell, Lindsey Clarke, Stephen Stewart, Austin Duffy, Cliona O'Farrelly
Journal: Journal of Hepatology (2024)
FRI-230-YI Prevalence and predictors of steatotic liver disease and significant liver fibrosis in an integrated hepatological and nonhepatological healthcare pathway model: preliminary results from a prospective cohort of a tertiary center
Authors: Angelo Armandi, Gian Paolo Caviglia, Guglielmo Beccuti, Alessandro Andreis, Federica Barutta, Matteo Bellettini, Chiara Rosso, Arianna Ferro, Irene Poggiolini, Giacomo Bonacchi, Gabriele Castelnuovo, Kamela Gjini, Fabrizio Amato, Martina Marano, Marta Guariglia, Eleonora Dileo, Nuria Pérez Diaz del Campo, Davide Giuseppe Ribaldone, Davide Castagno, Giorgio Maria Saracco, Gaetano De Ferrari, Gianluca Alunni, Mauro Rinaldi, Gabriella Gruden, Elisabetta Bugianesi
Journal: Journal of Hepatology (2024)
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Authors: Mathew Vithayathil, Antonio D'Alessio, Claudia Fulgenzi, Ciro Celsa, Giulia Manfredi, Naoshi Nishida, Martin Schoenlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Chun-yen Lin, Arndt Vogel, Bernhard Scheiner, Pei-Chang Lee, Yi-Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Valentina Zanuso, Tiziana Pressiani, Giuseppe Cabibbo, Andrea Dalbeni, Matthias Pinter, Amit Singal, Hong Jae Chon, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma
Journal: Journal of Hepatology (2024)
THU-493 Systemic therapy of hepatocellular carcinoma on non-cirrhotic liver: a prospective spanish multicentre study
Authors: Marta Romero-Gutiérrez, Jorge Barajas, Mariano Gómez, Laura Márquez, Sonia Pascual, Carlos Aracil, Raquel Latorre, Cristina Fernández, Teresa Ferrer, Cristina Alarcón, Vanesa Bernal, Mireia Miquel, Diana Horta, Jesús M. González, Bélen Piqueras, Dalia Morales, Maria Luisa Gutiérrez, Natalia Arietti, Pedro Barrera, Olga Ramos, Ana Matilla, Rafael Gómez Rodríguez
Journal: Journal of Hepatology (2024)
THU-456 Curative therapy after atezolizumab-bevacizumab and role of liquid biopsy in patient selection
Authors: Anand Kulkarni, P Kumaraswamy, Mithun Sharma, Balachandran Menon, Anuradha Sekaran, Sowmya Iyengar, Manasa Alla, Shantan Venishetty, Nagaraja Padaki, Nageshwar Reddy
Journal: Journal of Hepatology (2024)
SAT-528 Spleen stiffness measurement accurately predicts clinically significant portal hypertension in patients with hepatocellular carcinoma
Authors: Razvan Rababoc, Simu Razvan-Ioan, Simona Ioanitescu, Cristian Mugur Grasu, Mircea Istrate, Letitia Toma, Laura Iliescu
Journal: Journal of Hepatology (2024)
SAT-476 Development of a preference elicitation tool for treatment choice in unresectable, early/intermediate stage HCC
Authors: Andrew Moon, Daniel Richardson, Donna Evon, Hanna Sanoff, Jessica Carda-Auten, Myra Waheed, Gabrielle Ritaccio, Jamie Conklin, Ethan Basch, David Mauro, Ted Yanagihara, David Gerber, Neil Shah, Oren Fix, Tammy Triglianos, Jonathan Sorah, Jingquan Jia, Ashwin Somasundaram, A. Sidney Barritt
Journal: Journal of Hepatology (2024)
SAT-490 Competitive risk analysis of spleen stiffness measurement with a spleen-dedicated module (SSM@100 Hz) for predicting de-novo HCC occurrence in cACLD patients: a prospective 5-year follow-up study
Authors: Federico Ravaioli, Luigi Colecchia, Elton Dajti, Amanda Vestito, Arianna Gobbato, Francesca Lami, Matteo Renzulli, Matteo Serenari, Lorenza Di Marco, Francesco Tovoli, Silvia Ferri, Alessandra Pivetti, Dante Romagnoli, Francesco Azzaroli, Davide Festi, Antonio Colecchia, Giovanni Marasco
Journal: Journal of Hepatology (2024)
FRI-526 Role of the splicing factor PCBP2 in cholangiocarcinoma malignancy and chemoresistance
Authors: Candela Cives-Losada, Maria Reviejo, Maitane Asensio, Elisa Lozano, Sara Ortiz-Rivero, Maria J. Monte, Maria A. Serrano, Oscar Briz, Rocio Macias, Jose J.G. Marin
Journal: Journal of Hepatology (2024)
THU-457 Outcome of liver transplantation in patients with hepatocellular carcinoma previously treated with immune checkpoint inhibitorbased therapy-first results from an international multicenter registry
Authors: Ulrike Bauer, Najib Ben Khaled, Julia M. Grottenthaler, Friedrich Foerster, Sena Blümel, Sophia Heinrich, Friedrich Sinner, Marino Venerito, Richard Taubert, Andreas E. Kremer, Arndt Weinmann, Christoph P. Berg, Christian M. Lange, Enrico de Toni, Roland M. Schmid, Ursula Ehmer
Journal: Journal of Hepatology (2024)